Data from EPG Health Media - Curated by Toby Galbraith - Last updated 20 September 2017

Browse related ATC

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Monoclonal antibodies
edrecolomab
rituximab
trastuzumab
gemtuzumab
cetuximab
bevacizumab
panitumumab
catumaxomab
ofatumumab
ipilimumab
brentuximab vedotin
pertuzumab
trastuzumab emtansine
obinutuzumab
dinutuximab

Drug

Blitzima (Rituximab)

ATC
Orphan drug
No

Updated 21 days ago

Ritemvia (Rituximab)

ATC
Orphan drug
No

Updated 1 month ago

Rixathon▼ (Rituximab)

ATC
Orphan drug
No

Updated 1 month ago

Riximyo▼ (Rituximab)

ATC
Orphan drug
No

Updated 1 month ago

Dinutuximab beta Apeiron▼ (Dinutuximab beta)

ATC
Orphan drug
Yes

Updated 1 month ago

Truxima▼ (Rituximab)

ATC
Orphan drug
No

Updated 1 month ago

Unituxin (Dinutuximab)

ATC
Orphan drug
Yes

Updated 4 months ago

Gazyvaro▼ (Obinutuzumab)

ATC
Orphan drug
Yes

Updated 2 months ago

Kadcyla▼ (Trastuzumab Emtansine)

ATC
Orphan drug
No

Updated 1 month ago

Removab (Catumaxomab)

ATC
Orphan drug
No

Updated 2 months ago